Idogen AB (Sweden) Today
| IDOGEN Stock | SEK 0.12 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 86
|
Idogen AB is trading at 0.12 as of the 2nd of December 2024, a No Change since the beginning of the trading day. The stock's open price was 0.12. Idogen AB has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Idogen AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of December 2022 and ending today, the 2nd of December 2024. Click here to learn more.
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Idogen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Idogen AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Idogen AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology (View all Sectors) |
Idogen AB (IDOGEN) is traded on Stockholm Exchange in Sweden and employs 10 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 16.12 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Idogen AB's market, we take the total number of its shares issued and multiply it by Idogen AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Idogen AB has 104.37 M outstanding shares.
Idogen AB generates negative cash flow from operations
Check Idogen AB Probability Of Bankruptcy
Ownership AllocationIdogen AB has a total of 104.37 Million outstanding shares. Idogen AB retains 8.35 (percent) of its outstanding shares held by insiders and 0.42 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Idogen Ownership Details
Idogen Stock Against Markets
| IDOGEN | 0.00 |
|
| Competition | Refresh |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Idogen AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Aroon Oscillator Now
Aroon OscillatorAnalyze current equity momentum using Aroon Oscillator and other momentum ratios |
| All Next | Launch Module |
Idogen AB Corporate Management
Elected by the shareholders, the Idogen AB's board of directors comprises two types of representatives: Idogen AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Idogen. The board's role is to monitor Idogen AB's management team and ensure that shareholders' interests are well served. Idogen AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Idogen AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Prof MD | Founder Board | Profile | |
| Hanjing Xie | Chief Officer | Profile | |
| Mr MSc | Chief Officer | Profile | |
| Ingvar Karlsson | Chief Officer | Profile | |
| Rory Graham | Chief Officer | Profile | |
| Christina Herder | Acting Director | Profile |
Other Information on Investing in Idogen Stock
Idogen AB financial ratios help investors to determine whether Idogen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Idogen with respect to the benefits of owning Idogen AB security.